Tonix to Present Programs for PTSD, Fibromyalgia Drug Candidate at European Conference
News
Tonix Pharmaceuticals, a company dedicated to developing next-gen medicines for fibromyalgia and post-traumatic stress disorder (PTSD), announced its Executive Vice President of Commercial Planning and Development, Ronald Notvest, Ph.D., MBA, will present at the ... Read more